Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017
Latest news articles
Added 3 months ago Drug news
FDA grants 510(k) clearance for the CINtec Histology test to determine which women should receive treatment for cervical pre-cancer. Roche
Roche has announced it has received 510(k) clearance from the FDA for the CINtec Histology test. This test is the...
Added 5 months ago Drug news
First patient dosed in Phase III AIM2CERV trial evaluating axalimogene filolisbac as an adjuvant therapy for high-risk, locally advanced, carcinoma of the cervix. -Advaxis
Advaxis, Inc. announced that the first patient has been enrolled and dosed in its AIM2CERV (Advaxis IMmunotherapy 2 prevent CERVical...
Added 8 months ago Drug news
Successful phase III study (GOG-0265) of axalimogene filolisbac for recurrent metastatic (squamous or non-squamous cell) carcinoma of the cervix.- Advaxis Inc.
Advaxis, Inc. announced topline results from the early closure of stage 2 of the Phase II GOG-0265 trial, conducted by...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...
Added 5 years ago
Introduction: Cervical cancer is still a major cause of morbidity and mortality in women. Early stages and locally advanced cervical...
Added 1 year ago
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.
BACKGROUND: Despite preventive vaccines for oncogenic human papillomaviruses (HPVs), cervical intraepithelial neoplasia (CIN) is common, and current treatments are ablative...
Added 1 year ago
Cancer constitutes an enormous burden on society in more and less economically developed countries alike.
Added 2 years ago
Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more
Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.